NEW YORK (GenomeWeb) – Sigma-Aldrich today reported a 2 percent increase in its first-quarter sales as the firm fell short of the consensus analyst estimate on the top line but exceeded it on the bottom line.

For the three months ended March 31, the company reported sales of $689 million, up from $675 million in the year-ago quarter. Analysts had expected on average $690.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.